In addition, multiple studies have demonstrated a favorable TME emergence, including increased melanoma antigen expression, tumor-infiltrating CD8+ T cells (TILs) and other immunogenic cytokines signaling following the MAPK pathway inhibition with BRAFi/MEKi 79, 82, 83. Here, CD8A is linked to melanoma.